Literature DB >> 16461998

Regulatory T cell-mediated transplantation tolerance.

Ankit Bharat1, Ryan Courtney Fields, T Mohanakumar.   

Abstract

The existence of naturally occurring regulatory T cells in normal hosts and their pivotal role in maintaining both auto- and allo-tolerance have direct implications on the therapy of autoimmune disorders and for achieving immunosuppression-free allotransplantation. Among the various forms of regulatory T cells described, CD4(+)CD25(+) T cells have emerged as one of the most potent tolerogenic subsets. In this review, we discuss the molecular basis of development and function of these regulatory T cells and their potential role in the context of chronic lung allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16461998     DOI: 10.1385/IR:33:3:195

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  153 in total

1.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.

Authors:  Z X Zhang; L Yang; K J Young; B DuTemple; L Zhang
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation.

Authors:  A Yoshizawa; A Ito; Y Li; T Koshiba; S Sakaguchi; K J Wood; K Tanaka
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

3.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1970-05       Impact factor: 7.397

4.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

6.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

7.  Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.

Authors:  M A Smith; S Sundaresan; T Mohanakumar; E P Trulock; J P Lynch; D L Phelan; J D Cooper; G A Patterson
Journal:  J Thorac Cardiovasc Surg       Date:  1998-11       Impact factor: 5.209

8.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.

Authors:  Y Chen; J Inobe; V K Kuchroo; J L Baron; C A Janeway; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome.

Authors:  Federica Meloni; Patrizio Vitulo; Alessia Marone Bianco; Enrica Paschetto; Monica Morosini; Alessandro Cascina; Iolanda Mazzucchelli; Laura Ciardelli; Tiberio Oggionni; Anna Maria Fietta; Ernesto Pozzi; Mario Viganò
Journal:  Transplantation       Date:  2004-03-15       Impact factor: 4.939

10.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

View more
  11 in total

1.  Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling.

Authors:  Karl S Lang; Panco Georgiev; Mike Recher; Alexander A Navarini; Andreas Bergthaler; Mathias Heikenwalder; Nicola L Harris; Tobias Junt; Bernhard Odermatt; Pierre-Alain Clavien; Hanspeter Pircher; Shizuo Akira; Hans Hengartner; Rolf M Zinkernagel
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 2.  Allopeptides and the alloimmune response.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  Cell Immunol       Date:  2007-07       Impact factor: 4.868

3.  A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.

Authors:  V Tiriveedhi; N Angaswamy; D Brand; J Weber; A G Gelman; R Hachem; E P Trulock; B Meyers; G Patterson; T Mohanakumar
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 4.  Alloimmunity and autoimmunity in chronic rejection.

Authors:  Anil Seetharam; Venkataswarup Tiriveedhi; T Mohanakumar
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 5.  Clinical relevance of lung-restricted antibodies in lung transplantation.

Authors:  Mahzad Akbarpour; Qiang Wu; Xianpeng Liu; Haiying Sun; Emilia Lecuona; Rade Tomic; Sangeeta Bhorade; Thalachallour Mohanakumar; Ankit Bharat
Journal:  Hum Immunol       Date:  2019-05-08       Impact factor: 2.850

Review 6.  Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Nataraju Angaswamy; T Mohanakumar
Journal:  Hum Immunol       Date:  2012-07-10       Impact factor: 2.850

7.  Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.

Authors:  Haseeb Ilias Basha; Sabarinathan Ramachandran; Venkataswarup Tiriveedhi; Masashi Takenaka; Vijay Subramanian; Dilip S Nath; Nicholas Benshoff; G Alec Patterson; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

Review 8.  Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Authors:  Nataraju Angaswamy; Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Christina Klein; Jason Wellen; Surendra Shenoy; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

9.  Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis.

Authors:  A Bharat; F Barros; K Narayanan; B Borg; M Lisker-Melman; S Shenoy; J Lowell; J Crippin; W Chapman; T Mohanakumar
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

10.  Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K/AKT signaling.

Authors:  Ning Na; Daqiang Zhao; Jinhua Zhang; Jiaqing Wu; Bin Miao; Heng Li; Yingxun Luo; Zuofu Tang; Wensheng Zhang; Joseph A Bellanti; Song Guo Zheng
Journal:  Signal Transduct Target Ther       Date:  2020-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.